|   | 
										시장보고서
									 
											
												상품코드
											
										 
											1569464
										 녹내장 수술 기기 시장 규모, 점유율, 성장 분석 : 제품별, 수술 방법별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)Glaucoma Surgery Devices Market Size, Share, Growth Analysis, By Product, By Surgery Method, By End-use, By Region - Industry Forecast 2024-2031 | ||||||
녹내장 수술 기기 세계 시장 규모는 2022년 14억 달러로 평가되며, 2023년 14억 7,000만 달러에서 2031년에는 21억 2,000만 달러에 달할 것으로 예상되며, 예측 기간(2024-2031년) 동안 연평균 4.70%의 성장률을 보일 것으로 예상됩니다.
녹내장 수술 기기 시장은 특히 고령화 사회에서 녹내장 유병률의 증가로 인해 크게 성장할 것으로 예상됩니다. 이 안질환의 유병률이 증가함에 따라 효과적인 수술적 개입에 대한 수요도 증가하고 있으며, 성공률과 안전성 프로파일을 크게 개선한 수술 기술의 발전으로 뒷받침되고 있습니다. 최소침습 녹내장 수술(MIGS)로의 전환이 두드러지게 나타나고 있으며, 녹내장 배액 시스템 및 레이저 장비와 같은 장비는 합병증 발생률을 낮추고 환자 결과를 개선하여 인기를 얻고 있습니다. 또한, 관통형 마이크로바이패스 스텐트 및 맥락막상부 션트와 같은 기술을 특징으로 하는 최소침습적 수술의 추세는 백내장 수술과의 복합적 개입을 용이하게 하고 회복 기간을 단축시켜 시장에 혁명을 일으키고 있습니다. 녹내장 조기 발견과 조기 개입의 중요성에 대한 환자와 의료진의 인식이 높아지면서 시장 도입이 더욱 가속화되고 있습니다. 또한, 특히 북미와 유럽과 같은 신흥 시장에서는 유리한 상환 제도가 시장 확대를 촉진하고 있습니다. 더 나은 수술 결과를 촉진하는 환자 중심 치료의 중요성이 강조되면서 MIGS의 채택은 지속적으로 증가하고 있으며, 이는 성장의 매우 중요한 원동력이 되고 있습니다. 예측에 따르면, 미국 녹내장 수술 기기 시장은 향후 예측 기간 동안 건전한 CAGR을 유지할 것으로 예상되며, 이는 이 분야의 잠재력을 강조하고 있습니다.
Global Glaucoma Surgery Devices Market size was valued at USD 1.40 billion in 2022 and is poised to grow from USD 1.47 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 4.70% during the forecast period (2024-2031).
The glaucoma surgery devices market is on the brink of significant growth, primarily fueled by the escalating global incidence of glaucoma, particularly among the aging population. As the prevalence of this eye condition rises, the demand for effective surgical interventions is also increasing, supported by advancements in surgical techniques that have markedly improved success rates and safety profiles. A notable shift toward minimally invasive glaucoma surgery (MIGS) has been observed, with devices like glaucoma drainage systems and laser equipment gaining popularity for their reduced complication rates and enhanced patient outcomes. The trend toward less invasive procedures, characterized by techniques such as trabecular micro-bypass stents and suprachoroidal shunts, is revolutionizing the market, allowing for shorter recovery periods while facilitating combined interventions with cataract surgeries. Increased awareness among patients and healthcare providers about the critical importance of early glaucoma detection and intervention further drives market adoption. Additionally, favorable reimbursement frameworks, especially in developed regions like North America and Europe, bolster market expansion. With a heightened emphasis on patient-centered care that promotes better surgical outcomes, the adoption of MIGS is set to continue its upward trajectory, making it a pivotal driver of growth. According to projections, the US glaucoma surgery devices market is anticipated to sustain a healthy compound annual growth rate (CAGR) in the upcoming forecast period, underscoring the promising future of this sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the global glaucoma surgery devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
global glaucoma surgery devices Market Segmental Analysis
Global Glaucoma Surgery Devices Market is segmented by Product, Surgery Method, End-use, and region. Based on Product, the market is segmented into Glaucoma Drainage Device, Traditional Surgery Devices, Diamond Knives, Laser Systems, and Others. Based on Surgery Method, the market is segmented into Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, and Laser Surgery. Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the global glaucoma surgery devices Market
The global glaucoma surgery devices market is significantly driven by the aging population and a rise in lifestyle-related factors, including prolonged screen time and an increase in diabetes prevalence, which contribute to a higher incidence of glaucoma. This escalating prevalence necessitates effective surgical interventions, thus intensifying the demand for advanced glaucoma surgery devices. Additionally, heightened awareness among healthcare providers and patients regarding the critical importance of early detection and timely treatment of glaucoma amplifies this market growth. As the healthcare landscape continues to evolve, the pressing need for innovative surgical solutions to combat glaucoma will further bolster the market's expansion.
Restraints in the global glaucoma surgery devices Market
The global glaucoma surgery devices market faces a significant restraint due to the high cost associated with surgical procedures. Factors including the necessity for advanced, specialized equipment, the requirement for highly skilled healthcare providers, and comprehensive post-operative care contribute to increased expenses. Additionally, the cost of the devices themselves adds to the financial burden, making glaucoma surgeries unaffordable for many patients, particularly in developing regions or among those lacking sufficient insurance coverage. This economic barrier not only restricts patient access to essential surgical interventions but also hampers the overall growth potential of the glaucoma surgery devices market.
Market Trends of the global glaucoma surgery devices Market
The global glaucoma surgery devices market is witnessing a significant trend towards combination therapies, which integrate various treatment modalities to optimize intraocular pressure (IOP) management. This approach enhances therapeutic outcomes by leveraging the synergistic effects of medications, laser treatments, and surgical techniques. The emergence of advanced glaucoma devices that incorporate drug-delivery systems, such as sustained-release implants, exemplifies this trend, allowing for targeted and controlled drug administration alongside surgical interventions. As healthcare providers increasingly adopt these innovative solutions, the market is positioned for robust growth, driven by the demand for more effective and personalized glaucoma treatment options.